The Impact of Market Volatility on the Cell Therapy IndustryDavid Brindley, Chris Mason, Brock Reeve et al.|Cell stem cell|2011Cited by 30
The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012Chris Mason, Brock Reeve, Gregory A. Bonfiglio et al.|Cell stem cell|2012Cited by 27
Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market SentimentChris Mason, Brock Reeve, J. Mason et al.|Cell stem cell|2013Cited by 19
Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012David Brindley, Chris Mason, Natasha L. Davie et al.|Cell stem cell|2012Cited by 14
Investors unfazed by drug-patent expiryDavid Brindley, Chris Mason, Brock Reeve|Nature|2012Cited by 4